Remifentanil improves left ventricular diastolic parameters in patients with impaired diastolic function: a prospective clinical study

Table 3 Echocardiographic data

n = 30	Baseline	After Remifentanil	p
E (cm.sec^− 1)	70.3 ± 14.3	73.7 ± 18	0.17
A (cm.sec^− 1)	88.7 ± 20.4	89.3 ± 23	0.8
E/A ratio	0.8 ± 0.2	0.8 ± 0.2	0.43
Average e’ (cm.sec^− 1)	6.9 ± 1.3	7.8 ± 1.5*	< 0.001
Septal e’ (cm.sec^− 1)	6.2 ± 1.6	7.1 ± 1.8*	< 0.001
Lateral e’ (cm.sec^− 1)	7.6 ± 1.5	8.6 ± 1.5*	< 0.001
E/e’	10.6 ± 2.9	9.5 ± 2.3*	0.006
Mitral annular S velocity (Sm) (cm.sec^− 1)	7.8 ± 1.2	7.9 ± 1.2	0.6
DT (m.sec^− 1)	197 ± 48	189 ± 47	0.39
LVEF %	63.7 ± 6.5	64 ± 5.7	0.7
LVESV (ml)	27.7 ± 8	38.2 ± 9.7	0.67
LVEDV (ml)	76 ± 16.5	78 ± 21.5	0.37
LVESD	28.5 ± 3	27.9 ± 3	0.29
LVEDD	45 ± 4.5	45.7 ± 4	0.2
IVSD (cm)	9.9 ± 1.9	10 ± 1.6	0.8
LAVI (ml.m^− 2)	55 ± 14.5	51.6 ± 13.3	0.1
IVRT (m.sec^− 1)	99.7 ± 23.7	92.6 ± 25.4	0.08

Abbreviations: DT; deceleration time, LVESV-LVEDV; left ventricle end systolic and, end diastolic volume, LVESD-LVEDD; left ventricle end systolic and, end diastolic dimension, LAVI; left atrial volume index, LVEF; left ventricular ejection fraction, IVRT; isovolumic relaxation time, E; peak early, and A; peak late transmitral filling velocities, e; early diastolic velocities of the mitral annulus predefined as the average of the septal and lateral mitral annulus (average e’), IVSD; left ventricular internal diameter. * Statistically significant difference compared to baseline values

ISSN: 1471-2253